Real-world safety of carboplatin in non-small cell lung cancer: a retrospective signal detection and subgroup analysis based on the FAERS database
IntroductionCarboplatin is frequently employed in the treatment of non-small cell lung cancer (NSCLC), yet the real-world safety profile—including underrecognized adverse events (AEs) and subgroup-specific risk variations—remains incompletely understood. This study aims to systematically assess carb...
Saved in:
| Main Authors: | Lei Wang, Kunpeng Yang, Hui Zhao, Peiyun Lv, Chenglun Cai, Zhe Wang, Bao Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1590738/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A real-world pharmacovigilance study of Certolizumab pegol based on FAERS database
by: Meng Liu, et al.
Published: (2025-08-01) -
Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database
by: Ye Hu, et al.
Published: (2025-02-01) -
Analysis and mining of brodalumab adverse events based on FAERS database
by: Yue Wan, et al.
Published: (2025-05-01) -
The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Yutong Wu, et al.
Published: (2025-05-01) -
A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database
by: Xueping Shi, et al.
Published: (2025-04-01)